Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland.
Laboratory on Neurobiology of Compulsive Behaviors, National Institute on Alcohol Abuse and Alcoholism, Intramural Research Program, Bethesda, Maryland.
Biol Psychiatry. 2024 Nov 1;96(9):752-765. doi: 10.1016/j.biopsych.2024.05.020. Epub 2024 Jun 3.
Past research has illuminated pivotal roles of dopamine D receptors (DR) in the rewarding effects of cocaine and opioids. However, the cellular and neural circuit mechanisms that underlie these actions remain unclear.
We employed Cre-LoxP techniques to selectively delete DR from presynaptic dopamine neurons or postsynaptic dopamine D receptor (DR)-expressing neurons in male and female mice. We utilized RNAscope in situ hybridization, immunohistochemistry, real-time polymerase chain reaction, voltammetry, optogenetics, microdialysis, and behavioral assays (n ≥ 8 animals per group) to functionally characterize the roles of presynaptic versus postsynaptic DR in cocaine and opioid actions.
Our results revealed DR expression in ∼25% of midbrain dopamine neurons and ∼70% of DR-expressing neurons in the nucleus accumbens. While dopamine D receptors (DR) were expressed in ∼80% dopamine neurons, we found no DR and DR colocalization among these cells. Selective deletion of DR from dopamine neurons increased exploratory behavior in novel environments and enhanced pulse-evoked nucleus accumbens dopamine release. Conversely, deletion of DR from DR-expressing neurons attenuated locomotor responses to D-like and D-like agonists. Strikingly, deletion of DR from either cell type reduced oxycodone self-administration and oxycodone-enhanced brain-stimulation reward. In contrast, neither of these DR deletions impacted cocaine self-administration, cocaine-enhanced brain-stimulation reward, or cocaine-induced hyperlocomotion. Furthermore, DR knockout in dopamine neurons reduced oxycodone-induced hyperactivity and analgesia, while deletion from DR-expressing neurons potentiated opioid-induced hyperactivity without affecting analgesia.
We dissected presynaptic versus postsynaptic DR function in the mesolimbic dopamine system. DR and DR are expressed in different populations of midbrain dopamine neurons, regulating dopamine release. Mesolimbic DR are critically involved in the actions of opioids but not cocaine.
过去的研究已经阐明了多巴胺 D 受体(DR)在可卡因和阿片类药物的奖赏效应中的关键作用。然而,这些作用的细胞和神经回路机制仍不清楚。
我们使用 Cre-LoxP 技术选择性地删除雄性和雌性小鼠中多巴胺神经元的突触前 DR 或突触后多巴胺 D 受体(DR)表达神经元。我们利用 RNAscope 原位杂交、免疫组织化学、实时聚合酶链反应、伏安法、光遗传学、微透析和行为分析(每组≥8 只动物)来功能表征突触前与突触后 DR 在可卡因和阿片类药物作用中的作用。
我们的结果显示,DR 在中脑多巴胺神经元中表达约 25%,在伏隔核中 DR 表达神经元中表达约 70%。虽然多巴胺 D 受体(DR)在大约 80%的多巴胺神经元中表达,但我们在这些细胞中没有发现 DR 和 DR 的共表达。选择性地从多巴胺神经元中删除 DR 会增加新环境中的探索行为,并增强脉冲诱发的伏隔核多巴胺释放。相反,从 DR 表达神经元中删除 DR 会减弱对 D 样和 D 样激动剂的运动反应。引人注目的是,从任何一种细胞类型中删除 DR 都会减少羟考酮的自我给药和羟考酮增强的脑刺激奖励。相比之下,这些 DR 缺失都不会影响可卡因的自我给药、可卡因增强的脑刺激奖励或可卡因引起的过度运动。此外,DR 敲除降低了羟考酮诱导的多动和镇痛,而从 DR 表达神经元中删除则增强了阿片类药物诱导的多动而不影响镇痛。
我们剖析了中脑边缘多巴胺系统中突触前与突触后 DR 的功能。DR 和 DR 在不同的中脑多巴胺神经元群体中表达,调节多巴胺的释放。中脑边缘 DR 对阿片类药物的作用至关重要,但对可卡因则没有作用。